Back to search

University of Alabama Birmingham

Understanding Molecular Mechanisms of Glioblastoama Resistance to Design Novel Combinatorial Therapies

Abstract

dc:description.abstract

Treatment options for the universally lethal brain tumor, glioblastoma (GBM), are severely limited and often unsuccessful in fully eradicating the disease. Extremely aggressive in nature, GBM cells often implore suppressive mechanisms to evade therapeutic detection which aids in the dismal 15-month median survival rate. Facilitating disease severity and more importantly, disease recurrence, are the immunosuppressive and chemoresistant phenotypes of GBM cells. Specifically, the DNA alkylating agent, temozolomide (TMZ) possesses lymphodepleting properties shunting robust immune cell infiltration into an immunologically cold tumor microenvironment. Additionally, through inherent or acquired mechanisms, GBM tumors commonly become resistant to the DNA damaging effects of TMZ diminishing therapeutic potential. Our body of work utilizes both gamma-delta T cell mediated immunotherapy and tumor treating fields (TTFields) to overcome these respective hurdles. From our findings, we provide support that using DNA damage driven stress ligand induction via combined PARP inhibition with niraparib and DNA alkylation with TMZ aids in the gamma delta T cell mediated killing of GBM iv cells. Additionally, we demonstrate that TTFields can disrupt the growth of TMZ sensitive and resistant cells. Furthermore, we showed that combinatorial treatment of TTFields with the platelet derived growth factor receptor (PDGFR) inhibitor, crenolanib, further attenuated cell growth supporting our kinomic analysis predicting PDGFR as being increased potentially serving a compensatory survival mechanism. Interestingly in both of our investigation, there were varied levels of sensitivity to the respective treatments imploring further investigation to identify specific regulators. Collectively, we provide molecular basis for combinatorial strategies that can be further explored for therapeutic implementation in GBM.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jones, Amber B
Contributors dc:contributor
  • Anita Hjelmeland
  • Brittany Lasseigne
  • Christopher Ryan Miller
  • Rakesh Patel
  • Christopher Willey
  • Jianhua Zhang

Subjects

dc:subject × 7

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Jones, Amber B. Understanding Molecular Mechanisms of Glioblastoama Resistance to Design Novel Combinatorial Therapies. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/419